Neurology
Neurology
Advertisement
Lauren Dembeck, PhDNeurodivergent | July 8, 2025
Nutritional epigenetics may help prevent autism and ADHD via maternal diet changes.
Leslie FeldmanDementia | July 7, 2025
Excess brain iron in Down syndrome linked to oxidative damage and early-onset Alzheimer’s, new study finds.
Michael Wheeler, PhDMental Health | July 7, 2025
Psychedelics may ease depression and PTSD by reducing brain inflammation and restoring vascular and immune balance.
Pam BeilerGastroenterology | July 1, 2025
Wearables detect sleep changes tied to IBD inflammation—offering a new tool for real-time disease monitoring.
Izzah NawazNeurodivergent | June 27, 2025
A parent-focused therapy improved asthma control and ADHD symptoms in kids—while helping caregivers cope.
Anne Marie Morse, DOSleep Disorders | June 25, 2025
AI is transforming sleep medicine, boosting access, streamlining care, and empowering clinicians—not replacing them.
Jordana JampelNeurology | June 23, 2025
A father's mental health may have a more immediate impact on childhood development than previously believed.
Anne Marie Morse, DOSleep Disorders | June 19, 2025
Wearable sleep tech offers insights—but are we chasing data over real rest? Dr. Anne Marie Morse weighs in.
Rob Drolet, PhDNeurology | June 16, 2025
α-synuclein PET tracers may transform Parkinson’s diagnosis, tracking, and trials, says Merck’s Robert Drolet, PhD.
Leah LawrenceMental Health | June 13, 2025
Children who received a greater degree of maternal warmth at 3 years had greater perceived social safety at adolescence.
Leah LawrenceEpilepsy | June 12, 2025
Epilepsy and seizure drug use were significantly more common in patients with FTD vs those with Alzheimer’s.
Jordana JampelSLEEP 2025 | June 11, 2025
There are both positives and negatives associated with either testing method.
Jordana JampelSLEEP 2025 | June 11, 2025
The researchers focused on white matter microstructures in the relationship between REM-OSA and cognition decline.
Jordana JampelSLEEP 2025 | June 5, 2025
Most patients switching from modafinils to solriamfetol preferred it, citing better effects; others reverted due to side effe
Jordana JampelSLEEP 2025 | June 5, 2025
The drug was well-tolerated and adverse reactions were minimal to moderate in severity.
Jordana JampelSLEEP 2025 | June 5, 2025
The researchers considered age, sex, and race/ethnicity to determine differing pathophysiologies.
Jordana JampelDementia | May 16, 2025
The new blood test is less invasive and more accessible to patients.
Leah LawrenceNeurology | May 12, 2025
Ifetroban shows significant 12-month cardiac benefit in DMD patients, per phase-2 FIGHT DMD trial results.
Leah LawrenceNeurology | May 12, 2025
Apitegromab improves motor function in SMA patients aged 2–21, per phase-3 SAPPHIRE trial results.
Leah LawrenceNeurology | May 12, 2025
Losmapimod failed to show clinical benefit over placebo in FSHD patients in the phase 3 REACH trial, ending its development.
Advertisement